BioCentury

8:00 AM GMT, Dec 5, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Androxal enclomiphene: Phase II data

The single-blind, U.S. Phase II ZA-204 trial in 48 evaluable men with morning testosterone levels of <350 ng/dL showed that once-daily Androxal

Read the full 224 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.